Stock Events

Stock Events

Mayne Pharma Group Limited 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jan 23
€0.36
Mar 11
€0.16
Nov 10
€0.30
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

26AugExpected
Q4 2025
Q2 2026
-0.22
-0.15
-0.08
-0.01
Expected EPS
-0.20230817446399998
Actual EPS
-0.21536031475200001

Financials

-22.66%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
234.57MRevenue
-53.15MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HG6.STU. It's not an investment recommendation.
Westpac Banking
7
WBC.AU
Woodside Energy Group
6
WDS.AU
ANZ Group
6
ANZ.AU
National Australia Bank Limited
6
NAB.AU

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.46B
Teva Pharmaceutical Industries Ltd. is a global leader in generic medicines, directly competing with Mayne Pharma in the generics market.
Perrigo Company
PRGO
Mkt Cap2.01B
Perrigo Company plc specializes in over-the-counter healthcare products, competing with Mayne Pharma in the consumer health market.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson operates in the pharmaceutical, medical devices, and consumer health sectors, competing with Mayne Pharma particularly in the pharmaceutical and consumer health products sectors.
Pfizer
PFE
Mkt Cap159.36B
Pfizer Inc. is a global pharmaceutical corporation that competes with Mayne Pharma in the development and distribution of both generic and specialty pharmaceuticals.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie Inc. is a research-based biopharmaceutical company that competes with Mayne Pharma in the development and marketing of pharmaceutical products, particularly in areas like dermatology.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline plc is a global healthcare company that competes with Mayne Pharma in the pharmaceutical and healthcare sectors, including areas such as respiratory diseases, vaccines, and consumer healthcare products.

About

MAYNE PHARMA GROUP LTD
Show more...
CEO
Aaron Gray
Employees
450
Country
Australia
ISIN
AU000000MYX0
WKN
000A1C821

Listings

STU
DE
HG6.STU
AU
AU
MYX.AU
OTC Link
US
MAYNF
F
DE
HG6.F

0 Comments

Share your thoughts

FAQ

What is Mayne Pharma Group Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Mayne Pharma Group Limited stocks are traded under the ticker HG6.STU.
When is the next Mayne Pharma Group Limited earnings date?▼
Mayne Pharma Group Limited is going to release the next earnings report on February 24, 2027.
What were Mayne Pharma Group Limited earnings last quarter?▼
HG6.STU earnings for the last quarter are -0.22 EUR per share, whereas the estimation was -0.2 EUR resulting in a -6.45% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Mayne Pharma Group Limited revenue for the last year?▼
Mayne Pharma Group Limited revenue for the last year amounts to 234.57M EUR.
What is Mayne Pharma Group Limited net income for the last year?▼
HG6.STU net income for the last year is -53.15M EUR.
Does Mayne Pharma Group Limited pay dividends?▼
Yes, HG6.STU dividends are paid quarterly. The last dividend per share was 0.36 EUR. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Mayne Pharma Group Limited have?▼
As of September 04, 2026, the company has 450 employees.
In which sector is Mayne Pharma Group Limited located?▼
Mayne Pharma Group Limited operates in the Health & Wellness sector.
When did Mayne Pharma Group Limited complete a stock split?▼
The last stock split for Mayne Pharma Group Limited was on January 18, 2023 with a ratio of 1:20.
Where is Mayne Pharma Group Limited headquartered?▼
Mayne Pharma Group Limited is headquartered in Salisbury South, Australia.